Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis

Table 3

Clinical outcomes of Fusarium, Aspergillus, and Dematiaceous keratitis.

Groups	Mean visual acuity; before treatment; (LOGMAR)	Mean visual acuity after treatment (LOGMAR)	Change in visual acuity			Worsened
			Poor response; (No PL to PL/PL to PR)	Slight response; (improved Snelens/; CF to Snelens)	Good response; (PL to CF/Snelens)
Fusarium	1.82 (0.8–3)	1.17 (0–3)	3 (20%)	8 (53.3%)	3 (20%)	1 (6.7%)
Aspergillus	2.08 (0.48–3)	1.68 (0–3)	4 (16.7%)	12 (49.9%)	5 (20.9%)	3 (12.5%)
Dematiaceous	2.45 (0.48–3)	0.91 (0–2)	0	3 (30%)	7 (70%)*	0

∗P value <0.05 when compared to the other two groups.